The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
about
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model.Novel antibacterial agents for the treatment of serious Gram-positive infections.In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinoloneIn vitro activities of new antimicrobials against Nocardia brasiliensisIn vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.Mutant selection window hypothesis updated.Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases.In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
P2860
Q34139244-35091C4D-19E3-479A-B7DA-BCEE8D6C2367Q34141733-9897F282-D338-4C3B-AB60-44782FCF4BAEQ34230600-03FB87BB-E369-4905-BA20-75D5E9E6A6A8Q34301493-D6E44B42-F794-498B-84B1-C2ED0E9F21AEQ35073345-231F1F26-7AAC-4D27-AE45-4A86D0A13998Q35127828-7AA9DF75-543C-40AA-94F4-ABB1712CCA0AQ35547190-D6BDF001-CDC3-40AB-9A90-5A1DFE92E863Q36491256-9492ACD4-4C30-4717-9DC5-BC9AC85DAA22Q36728061-07BB73CB-219B-4EC7-B7CA-A52C08387258Q39731800-61457CA8-473E-4232-87F9-8F5C43F521FBQ39731893-18CF7F59-A39C-420F-98B8-2CAF6F2143CDQ39792656-4DDBAF40-7415-4FA3-B0B1-AA97D0882B38Q40130484-E27AEB1D-B294-4C9E-81A1-9EC1CB685E03Q41217457-285ADB6C-2EDE-4448-A1CC-CB75A8C54C98
P2860
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@en
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@nl
type
label
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@en
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@nl
prefLabel
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@en
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@nl
P2093
P356
P1476
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
@en
P2093
P304
P356
10.1093/JAC/49.1.177
P407
P577
2002-01-01T00:00:00Z